These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing, reported early||2004-004404-21||Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences||not-yet-due|
|Completed, but no date, and reported results||2006-004296-35||An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatment||bad-data|
|Not reported||2007-001281-33||A randomised control trial of alternative treatments to Inhibit VEGf in Age-related choroidal Neovascularisation(IVAN)||2013-12-31||due-trials|
|Ongoing, reported early||2008-002287-33||Effect of HMG-Co A reductase inhibition on endothelial dysfunction, bioavailability of tetrahydrobiopterin (BH4) and functional regulation of endothelial nitric oxide synthase (eNOS) in human heart fa...||not-yet-due|
|Ongoing, reported early||2008-003293-18||Pharmacokinetics of ketamine in infants||not-yet-due|
|Ongoing||2009-016566-82||Skin bacteria as a source of surgical infections: molecular epidemiology and prevention of wound contaimination||not-yet-due|
|Not reported||2013-001664-34||Vit-D in CRC - A Randomised Double Blind Placebo-Controlled Clinical Trial Of a Single Oral Cholecalciferol Treatment Against Surrogate End Point Biomarkers (SEBs) In Colon Cancer (CRC) Patients||2018-04-24||due-trials|